Table 3

Two-year Kaplan-Meier event rates by TRS 2°P and subgroup

TRS 2°PPtrend
≤234≥5
Full trial population
 n4,0345,5164,2212,717
 CV death1.02.14.16.8<0.001
 MI1.52.73.57.1<0.001
 Ischemic stroke1.01.42.43.0<0.001
All CAD
 n1,5773,2453,0752,379
 CV death1.32.34.26.5<0.001
 MI2.93.43.97.5<0.001
 Ischemic stroke1.11.32.22.9<0.001
CAD with no prior MI
 n1,1181,429992501
 CV death1.31.75.06.3<0.001
 MI2.53.72.86.50.019
 Ischemic stroke1.11.82.52.80.014
Prior MI
 n4591,8162,0831,878
 CV death1.32.73.86.6<0.001
 MI3.73.34.47.8<0.001
 Ischemic stroke0.90.82.12.9<0.001
PAD
 n1565626046,363
 CV death2.22.05.49.9<0.001
 MI0.92.02.210.2<0.001
 Ischemic stroke1.30.63.73.20.006
Prior stroke
 n130697663604
 CV death0.01.62.47.5<0.001
 MI0.82.03.58.7<0.001
 Ischemic stroke4.32.54.05.10.039
  • Data are percentages unless otherwise indicated.